Virology & Infectious Diseases RFP Opportunities

Creating-Possible-Fund-HeroBanner
Some content on this site is not intended for people outside of the United States.

RFP Programs

Program Description LOI Due Date
HIV: RESONATE 2026, BIC/LEN PDF Icon Research to support clinical & community decisions and medical management of HIV May 4, 2026

.

Application Criteria

Gilead will evaluate all Concepts addressing the following topics of interest (TOI) on a rolling basis until funds are exhausted.*

Research Topic: Implementation of updated HBV treatment guidelines and shared-decision making (SDM) and its impact on HBV treatment initiation and/or clinical outcomes.

  • In what ways can SDM address patient, provider, and system-level barriers to HBV care under the updated HBV treatment guideline recommendations, and what patient-centered criteria are essential for effective HBV SDM tools?
  • How should SDM be operationalized and sustainably integrated into HBV care, and what impact does its implementation have on HBV treatment initiation, adherence, and disease control?

*Concepts only proposing new implementation of HBV testing alone will not be considered.

Application Criteria

Gilead will evaluate all concepts received on a rolling basis until funds are exhausted. This TOI program is open to all geographies. The program will consider concepts which focus on the topics below:

Linkage to care and treatment of HCV+ pregnant patients through multi-specialty coordination:

  • Studies which implement models of care supporting informed treatment initiation for HCV+ pregnant patients, including post-treatment follow up and post-partum outcomes

Implementation and optimization of HDV testing and linkage to care strategies to improve identification of HDV infection and timely connection to appropriate specialty care in the United States.

  • To evaluate feasibility, adoption, reach, and linkage-to-care outcomes of reflex or double-reflex HDV testing among HBsAg-positive populations across healthcare systems, with a focus on community clinics, Federally Qualified Health Centers (FQHCs) and safety-net hospitals.
  • To characterize variations in the HDV care cascade across community clinics, FQHCs and safety-net hospitals, geographies, and patient sub‑populations defined by social determinants of health and higher HDV burden, and identify, implement, and evaluate best‑practice or evidence‑based strategies to address critical linkage‑to‑care drop‑offs.

Apply for Research Funding

Together, we can generate critical, high-quality research that has an impact on clinical decision-making and patients’ lives.

Apply Now